Screener
Roivant Sciences ROIV Other — Deferred Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The source filing: Roivant Sciences’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:17 AM EDT
- Fiscal year
- FY2025
- Accession
- 0001635088-26-000061
| Current taxes: / Bermuda | Years Ended March 31, 2026 / $ | Years Ended March 31, 2026 / — | Years Ended March 31, 2025 / $ | Years Ended March 31, 2025 / — | Years Ended March 31, 2024 / $ | Years Ended March 31, 2024 / — |
|---|---|---|---|---|---|---|
| Total current tax expense | $ | $133,329 | $ | $48,174 | $ | $21,503 |
| Deferred taxes: | ||||||
| Bermuda | $ | — | $ | — | $ | — |
| United States | — | — | — | |||
| Switzerland | — | — | — | |||
| Other | — | — | — | |||
| Total deferred tax benefit | $ | — | $ | — | $ | — |
| Total income tax expense | $ | $133,329 | $ | $48,174 | $ | $21,503 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Roivant Sciences's other — deferred income tax expense benefit?
- Roivant Sciences (ROIV) reported other — deferred income tax expense benefit of $0 in Q1 2026.
- What does other — deferred income tax expense benefit mean?
- This metric captures the non-cash tax expense or benefit arising from temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases within the 'Other' segment. It reflects the future tax consequences of current transactions that will be realized in later periods. It is a key indicator of how accounting choices and timing differences impact the segment's future tax obligations.
Ask your AI about Roivant Sciences's other — deferred income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude